We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+20.98%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$43.6B
AUM Growth
+$6.24B
Cap. Flow
-$68.6M
Cap. Flow %
-0.16%
Top 10 Hldgs %
18.5%
Holding
2,867
New
114
Increased
867
Reduced
1,441
Closed
109

Top Sells

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$115M
2
AGN
Allergan plc
AGN
+$67M
3
JNJ icon
Johnson & Johnson
JNJ
+$65.6M
4
AON icon
Aon
AON
+$61.8M
5
SYY icon
Sysco
SYY
+$56.1M

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Financials 18.57%
3 Healthcare 11.27%
4 Consumer Discretionary 9.72%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAI icon
2301
BioXcel Therapeutics
BTAI
$28.7M
$39K ﹤0.01%
+46
New +$30K
CASS icon
2302
Cass Information Systems
CASS
$734M
$39K ﹤0.01%
988
+4
+0.4% +$150
CDXS icon
2303
Codexis
CDXS
$161M
$39K ﹤0.01%
3,446
IVV icon
2304
iShares Core S&P 500 ETF
IVV
$904B
$39K ﹤0.01%
127
-379
-75% -$111K
PEBO icon
2305
Peoples Bancorp
PEBO
$1.46B
$39K ﹤0.01%
1,828
-24
-1% -$525
SHYF
2306
DELISTED
The Shyft Group
SHYF
$39K ﹤0.01%
2,325
-9
-0.4% -$136
SRI icon
2307
Stoneridge
SRI
$203M
$39K ﹤0.01%
1,885
VVX icon
2308
V2X
VVX
$2.6B
$39K ﹤0.01%
797
LBAI
2309
DELISTED
Lakeland Bancorp Inc
LBAI
$39K ﹤0.01%
3,486
+60
+2% +$646
JCAP
2310
DELISTED
Jernigan Capital, Inc.
JCAP
$39K ﹤0.01%
2,887
-22
-0.8% -$283
ATEX icon
2311
Anterix
ATEX
$1.81B
$38K ﹤0.01%
834
CVM icon
2312
CEL-SCI Corp
CVM
$26M
$38K ﹤0.01%
+86
New +$35.3K
NVEC icon
2313
NVE Corp
NVEC
$573M
$38K ﹤0.01%
618
+8
+1% +$457
SWTX
2314
DELISTED
SpringWorks Therapeutics
SWTX
$38K ﹤0.01%
+905
New +$32.2K
SPWR
2315
DELISTED
SunPower Corporation Common Stock
SPWR
$38K ﹤0.01%
7,681
PRVB
2316
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$38K ﹤0.01%
+2,708
New +$34.2K
ANAT
2317
DELISTED
American National Group, Inc. Common Stock
ANAT
$38K ﹤0.01%
529
-39
-7% -$2.92K
EBSB
2318
DELISTED
Meridian Bancorp, Inc.
EBSB
$38K ﹤0.01%
3,336
+22
+0.7% +$244
TBIO
2319
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$38K ﹤0.01%
2,145
AKRO
2320
DELISTED
Akero Therapeutics
AKRO
$37K ﹤0.01%
+1,488
New +$34K
ANAB icon
2321
AnaptysBio
ANAB
$1.64B
$37K ﹤0.01%
1,686
ARQT icon
2322
Arcutis Biotherapeutics
ARQT
$3.26B
$37K ﹤0.01%
+1,218
New +$35.2K
BDTX icon
2323
Black Diamond Therapeutics
BDTX
$114M
$37K ﹤0.01%
+879
New +$32.4K
CODX
2324
Co-Diagnostics
CODX
$5.53M
$37K ﹤0.01%
+65
New +$29.7K
CRBP icon
2325
Corbus Pharmaceuticals
CRBP
$177M
$37K ﹤0.01%
+149
New +$30.1K

Similar funds

Canada Life's Q2 2020 Portfolio in Review

As of Q2 2020, Canada Life held 2,867 positions worth $43.6B, up 17% from $37.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Canada Life's Q2 2020 filing shows 114 new, 867 increased, 1,441 reduced and 109 closed positions. Its largest new stake was Johnson Controls International: 3,791,146 shares worth $129M. The largest sale was Franco-Nevada, an estimated $115M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Canada Life's largest Q2 2020 buy was Johnson Controls International: 3,791,146 shares worth $129M.
  • Canada Life added most to Amazon in Q2 2020, an estimated $69.6M increase.
  • Canada Life's biggest Q2 2020 reduction was Franco-Nevada, cutting an estimated $115M.
  • Canada Life fully exited Allergan plc in Q2 2020, selling an estimated $67M.
  • Canada Life's ten largest holdings make up 19% of its $43.6B portfolio in Q2 2020.
  • Canada Life opened 114 new positions and closed 109 in Q2 2020.
  • Canada Life's portfolio value rose 17% quarter-over-quarter to $43.6B.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.